These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32649317)

  • 1. Microcrystalline Cellulose and Crospovidone Identified in Placentas With Vaginal Misoprostol Use.
    Butler DC; Presnell SE; Bruner E; Page T; Cuff R; Phillips A
    Am J Forensic Med Pathol; 2020 Sep; 41(3):176-181. PubMed ID: 32649317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misoprostol associated refractile material in fetal and placental tissues after medical termination of pregnancy.
    Ho V; Keating S; Kingdom J; Shannon P
    Am J Surg Pathol; 2007 Dec; 31(12):1893-6. PubMed ID: 18043045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crospovidone and Microcrystalline Cellulose: A Novel Description of Pharmaceutical Fillers in the Gastrointestinal Tract.
    Shaddy SM; Arnold MA; Shilo K; Frankel WL; Harzman AE; Stanich PP; Singhi AD; Yearsley MM; Arnold CA
    Am J Surg Pathol; 2017 Apr; 41(4):564-569. PubMed ID: 28009603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the abortion interval of second trimester pregnancy termination using misoprostol.
    Ting WH; Peng FH; Lin HH; Lu HF; Hsiao SM
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):408-11. PubMed ID: 26384060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of vaginal misoprostol versus vaginal misoprostol and isosorbide dinitrate for termination of pregnancy at 13-29 weeks.
    Hidar S; Bouddebous M; Chaïeb A; Jerbi M; Bibi M; Khaïri H
    Arch Gynecol Obstet; 2005 Dec; 273(3):157-60. PubMed ID: 16041629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination route versus sublingual and vaginal misoprostol for the termination of 13 to 24 week pregnancies: A randomized clinical trial.
    Rahimi-Sharbaf F; Adabi K; Valadan M; Shirazi M; Nekuie S; Ghaffari P; Khansari N
    Taiwan J Obstet Gynecol; 2015 Dec; 54(6):660-5. PubMed ID: 26700981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy by Oppegaard et al.
    Nzewi C
    BJOG; 2006 Aug; 113(8):979-80. PubMed ID: 16907951
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of vaginal misoprostol and gemeprost as pre-treatment in first trimester pregnancy interruption.
    Henry AM; Haukkamaa M
    Br J Obstet Gynaecol; 1999 Jun; 106(6):540-3. PubMed ID: 10426610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial.
    Tanha FD; Golgachi T; Niroomand N; Ghajarzadeh M; Nasr R
    Arch Gynecol Obstet; 2013 Jan; 287(1):65-9. PubMed ID: 22903515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose vaginal misoprostol with or without Foley catheter for late second-trimester pregnancy termination in women with previous multiple cesarean sections.
    El Sharkwy IAE; Elsayed ML; Ahmed MA; Alnemer AAA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3703-3707. PubMed ID: 29742942
    [No Abstract]   [Full Text] [Related]  

  • 12. Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy - a systematic review.
    Gómez Ponce de León R; Wing DA
    Contraception; 2009 Apr; 79(4):259-71. PubMed ID: 19272495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of dry tablet insertion versus gel form of vaginal misoprostol for second trimester pregnancy termination.
    Pongsatha S; Tongsong T
    J Obstet Gynaecol Res; 2008 Apr; 34(2):199-203. PubMed ID: 18412782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming?
    Singh K; Fong YF; Prasad RN; Dong F
    Hum Reprod; 1999 Jun; 14(6):1635-7. PubMed ID: 10357990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral misoprostol vs. vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second-trimester.
    Fadalla FA; Mirghani OA; Adam I
    Int J Gynaecol Obstet; 2004 Jul; 86(1):52-3. PubMed ID: 15207678
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial.
    Oppegaard KS; Qvigstad E; Nesheim BI
    BJOG; 2006 Jan; 113(1):58-64. PubMed ID: 16398773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Termination of early pregnancy with a reduced oral dose of mifepristone and vaginal misoprostol.
    Anjum ZK
    S Afr Med J; 2000 Sep; 90(9):889-91. PubMed ID: 11081141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal misoprostol vs vaginal misoprostol for first trimester termination of pregnancy.
    Okman-Kilic T; Kucuk M
    Int J Gynaecol Obstet; 2004 Apr; 85(1):64-5. PubMed ID: 15050476
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.
    Nuthalapaty FS; Ramsey PS; Biggio JR; Owen J
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1065-70. PubMed ID: 16157113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination.
    Bebbington MW; Kent N; Lim K; Gagnon A; Delisle MF; Tessier F; Wilson RD
    Am J Obstet Gynecol; 2002 Oct; 187(4):853-7. PubMed ID: 12388963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.